ICICI Bank & Divi’s Labs at Record Highs: Muhurat Trading Catalysts

MUMBAI, NOVEMBER 08, 2026 — During the special Diwali Muhurat trading session ushering in Samvat 2083 on Sunday, November 08, 2026, shares of Divi’s Laboratories surged 6% to an all-time peak of ₹10,950 on the National Stock Exchange (NSE), while private banking heavyweight ICICI Bank touched a fresh record high. The moves led a broader advance where 14 constituents of the NSE 500 index logged fresh lifetime highs, anchored by Divi’s reporting a 64% year-on-year surge in consolidated net profit for the second quarter (Q2 FY27) and sustained institutional broker upgrades for private lenders.

Key triggers and Session Timeline for Samvat 2083

The one-hour Muhurat trading session represents a long-standing ceremonial tradition on Indian bourses marking the start of the Hindu accounting year, Samvat 2083. While trading volumes are typically compressed within the 60-minute window, institutional flows often establish early momentum across top-performing sectors. Real-time market breadth tracked on the Indian market indices dashboard reflected steady risk-on positioning across healthcare, private lenders, and capital goods.

Spotlight Stocks: Record High Metrics and Earnings Comparison

According to exchange disclosures submitted to NSE India and BSE India, trading interest concentrated heavily around large-cap compounders with visible earnings delivery. Divi’s Laboratories witnessed sharp buying after its quarterly numbers outperformed street projections, driven by increased capacity utilization and volume recovery in its custom synthesis exports. Meanwhile, ICICI Bank sustained institutional interest as research notes from Geojit, PL Capital, and Shriram Research featured the private sector lender prominently across their Samvat 2083 institutional allocations.

Earnings Trajectory and Sector Analysis for ICICI Bank and Divi’s

Divi’s Laboratories has seen earnings momentum accelerate on the back of stabilized raw material pricing and expanding API export contracts into Europe and North America. The 64% net profit expansion reported in its Q2 FY27 print confirmed operating leverage across its key manufacturing facilities, prompting institutional re-evaluations. Investors closely monitoring secondary market leaders often compare market moves with the recent IPO listing performance tracker to gauge equity risk appetite across cyclical versus defensive themes.

For ICICI Bank, the push into record territory reflects structural preference among foreign institutional investors (FIIs) and domestic mutual funds. Following its initial Q2 print on October 19, 2026, where the stock slipped 1% amid broader Nifty profit-booking, institutional brokerages maintained positive stances on the bank’s return on equity (RoE) profile, asset quality consistency, and steady credit expansion in retail and SME portfolios. Brokerage strategy notes issued between November 04 and November 07 by firms including PL Capital, Geojit, and Shriram Research cited ICICI Bank as a core large-cap holding for Samvat 2083.

Balanced Investor Framework: Core triggers vs. Market Headwinds

Growth Drivers and Positive Tailwinds

• Operational Turnaround in Active Ingredients: Divi’s Laboratories’ 64% net profit expansion highlights sustained demand recovery in CDMO contracts and high-value generic APIs.
• Durable Balance Sheet Metrics: ICICI Bank continues to demonstrate strong net interest margins (NIMs) relative to peers and controlled credit costs across economic cycles.
• Broad Market Participation: Across the NSE 500, 14 firms setting new highs signals that selective stock picking is rewarding companies with proven quarterly earnings delivery.

Downside Risks and Valuation Pressures

• Elevated Valuation Multiples: Divi’s Laboratories trading at ₹10,950 leaves little margin for error if global pharmaceutical destocking re-emerges.
• Cost of Funds Challenges: Commercial banks face competitive pressure on deposit accretion, which could compress net interest margins in subsequent quarters of FY27.
• Liquidity Thinness in Muhurat Sessions: One-hour trading sessions can display amplified price swings due to lower aggregate trading turnover compared to regular market days.

Frequently Asked Questions

Why did Divi’s Laboratories surge 6% to reach ₹10,950?

Divi’s Laboratories rallied 6% to an all-time high of ₹10,950 during the Muhurat session following a 64% year-on-year increase in its Q2 FY27 consolidated net profit. The surge reflected institutional enthusiasm over margin recovery and expanded export contract execution in its custom synthesis business.

What drove ICICI Bank to touch a fresh record high?

ICICI Bank touched record levels due to sustained institutional accumulation after multiple brokerage strategy reports for Samvat 2083 highlighted its consistent return ratios, robust asset quality, and healthy credit growth across retail and corporate verticals.

How many NSE 500 stocks established new lifetime peaks during the session?

A total of 14 stocks within the NSE 500 index printed fresh lifetime highs during the one-hour Diwali Muhurat trading session on November 08, 2026, demonstrating targeted capital allocation into fundamentally resilient large-cap and mid-cap companies.

Sources referenced: Business Standard Markets, NSE India filings, BSE India corporate announcements, Livemint, Moneycontrol, The Economic Times.

Reusing this article or its images? Credit IPO Bulletin and link to https://ipobulletin.com/news/icici-bank-divi-s-labs/. Content licence.